Sponsored by the City of Changsha, China and co-organized by Central South University and Yao Yuan—Academy for Pharma Innovation, Yao Yuan’s 4th Biotech-Pharma International Symposium will be held on November 10-16, 2012 in Changsha/Zhangjiajie, China. The theme of the conference is “Global Coalition, A Synergistic Path to Biopharma Innovation” to highlight our goal in exploring a healthy, innovative, and rejuvenated model for future avenues of biotech and pharmaceutical development. This particular symposium attempts to diagnose the decline in current pharmaceutical R&D efficiency, emphasize the latest but successful pharmaceutical innovations, and propose feasible and effective solutions to the challenging environment facing the pharmaceutical industry. The 1st day of the three-day event will be held in Changsha National High-Tech Industrial Development Zone, focusing on strategic diagnoses of the current pharmaceutical challenges, and searching for potential solutions. The rest of the symposium will be held in Empark Grand Hotel and aims to highlight the latest advances in pharmaceutical innovations along with successful stories in development. An optional 3-day tour to Zhangjiajie, the most picturesque national park in China, as mayor’s VIP guests is also planned following the main symposium. We look forward to another exciting conference and to seeing you in Changsha, China.
Conference Time: November 10-16, 2012
Place: Changsha/Zhangjiajie (China)
Featured Speakers:
Keith R. Yamamoto, Ph.D, Vice Chancellor & Executive Vice Dean of the School of Medicine, University of California, San Francisco
Chun-Su Yuan, M.D., Ph.D., Cyrus Tang Professor & Director, Tang Center for Herbal Medicine Research, the University of Chicago
Peter H. Seeberger, Ph.D, Director at Max Planck Institute of Colloids and Interfaces (Former Institute of Organic, Physical & Polymer Chemistry); Professor at Institute of Chemistry and Biochemistry, Free University Berlin & at Burnham Institute; Founder of Ancora Pharmaceuticals and I2chem; Former President of the Swiss Academy of Natural Sciences
P. Mark Hogarth, MD, Distinguished Professor & Director, Burnet Institute, Australia; Senior Principal Research Fellow of the NHMRC
Kaixian Chen, Ph.D, Academician, Chinese Academia of Science; President & Professor, Shangai University of TCM
Jian Ding, Ph.D, Academician, Chinese Academia of Engineer; Director and Professor, Shanghai Institute of Meteria Medica, Chinese Academia of Chinese
Hiroshi Sugiyama, Ph.D, Distinguished Professor, Kyoto University, Japan
Brian S. J. Blagg, Ph.D., Professor of Medicinal Chemistry, The University of Kansas; Senior Editor, The Journal of Medicinal Chemistry
Peter Senter, Ph.D, Vice President, Seattle Genetics
Songlin Xue, MD, Sr. Vice President, Takeda
Terry Opgenorth, Ph.D, CEO, Vidasym Inc.; Vice President, Colorado State University Ventures (Former Vice President, Metabolic Disease, Abbott Laboratories)
Wenqing Yao, Ph.D, Sr. Vice President, Incyte Pharmaceutical
Giovanni Melillo, Ph.D, Medical Director, Oncology at Bristol-Myers Squibb; Former Head of Tumor Hypoxia Section, National Cancer Institute